Back to Search
Start Over
Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylorivaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial
- Source :
- The Lancet; October 2015, Vol. 386 Issue: 10002 p1457-1464, 8p
- Publication Year :
- 2015
-
Abstract
- Helicobacter pyloriis one of the most common gastric pathogens, affecting at least half the world's population, and is strongly associated with gastritis, peptic ulcer, gastric adenocarcinoma, and lymphoma. We aimed to assess the efficacy, safety, and immunogenicity of a three-dose oral recombinant H pylorivaccine in children in China.
Details
- Language :
- English
- ISSN :
- 01406736 and 1474547X
- Volume :
- 386
- Issue :
- 10002
- Database :
- Supplemental Index
- Journal :
- The Lancet
- Publication Type :
- Periodical
- Accession number :
- ejs36273322
- Full Text :
- https://doi.org/10.1016/S0140-6736(15)60310-5